Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

302 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia.
Torres A, Serrano J, Rojas R, Martín V, Martín C, Tabares S, Molina JR, Capote M, Martínez F, Gómez P, Sánchez-García J. Torres A, et al. Eur J Haematol. 2010 Mar;84(3):271-3. doi: 10.1111/j.1600-0609.2009.01367.x. Epub 2009 Oct 29. Eur J Haematol. 2010. PMID: 19878274 Clinical Trial. No abstract available.
Tumor necrosis factor-α-secreting CD16+ antigen presenting cells are effectively removed by granulocytapheresis in ulcerative colitis patients.
Sanchez-Garcia J, Serrano-López J, García-Sanchez V, Alvarez-Rivas MA, Jimenez-Moreno R, Pérez-Seoane C, Herrera-Arroyo C, Serrano J, de Dios JF, Torres-Gomez A. Sanchez-Garcia J, et al. J Gastroenterol Hepatol. 2010 Dec;25(12):1869-75. doi: 10.1111/j.1440-1746.2010.06377.x. J Gastroenterol Hepatol. 2010. PMID: 21091999
Voriconazole as primary antifungal prophylaxis in children undergoing allo-SCT.
Molina JR, Serrano J, Sánchez-García J, Rodríguez-Villa A, Gómez P, Tallón D, Martín V, Rodríguez G, Rojas R, Martín C, Martínez F, Alvarez MA, Torres A. Molina JR, et al. Bone Marrow Transplant. 2012 Apr;47(4):562-7. doi: 10.1038/bmt.2011.111. Epub 2011 May 16. Bone Marrow Transplant. 2012. PMID: 21572466 Clinical Trial.
Quantification of minimal residual disease levels by flow cytometry at time of transplant predicts outcome after myeloablative allogeneic transplantation in ALL.
Sanchez-Garcia J, Serrano J, Serrano-Lopez J, Gomez-Garcia P, Martinez F, Garcia-Castellano JM, Rojas R, Martin C, Rodriguez-Villa A, Molina-Hurtado JR, Alvarez MA, Casaño J, Torres-Gomez A. Sanchez-Garcia J, et al. Bone Marrow Transplant. 2013 Mar;48(3):396-402. doi: 10.1038/bmt.2012.147. Epub 2012 Jul 30. Bone Marrow Transplant. 2013. PMID: 22858507
Cytoplasmic localization of wild-type survivin is associated with constitutive activation of the PI3K/Akt signaling pathway and represents a favorable prognostic factor in patients with acute myeloid leukemia.
Serrano-López J, Serrano J, Figueroa V, Torres-Gomez A, Tabares S, Casaño J, Fernandez-Escalada N, Sánchez-Garcia J. Serrano-López J, et al. Haematologica. 2013 Dec;98(12):1877-85. doi: 10.3324/haematol.2013.083642. Epub 2013 Jun 28. Haematologica. 2013. PMID: 23812937 Free PMC article.
302 results